Mount Sinai
Mount Sinai
Publications
17
Total Publications
6
Abstract/Manuscript
11
Poster Presentation
2025 · Poster Presentation · AbbVie Inc. · Dermatology
Correlation between achieving SALT 20 score and clinician- and patient-reported outcomes among patients diagnosed with alopecia areata in the US: An assessment from the TARGET-DERM AA registry
Read more →2025 · Poster Presentation · Northwestern University · Dermatology
Race and ethnicity sub-groups of alopecia areata patients have differing clinical characteristics: TARGET-DERM AA
Read more →2025 · Poster Presentation · AbbVie Inc. · Dermatology
Generic vs. disease-specific patient reported outcome (PRO) instruments for assessing HRQoL burden among patients diagnosed with alopecia areata: Evidence from TARGET-DERM AA
Read more →2024 · Poster Presentation · Medical University of South Carolina · Dermatology
Demographics and disease characteristics of patients with alopecia areata with comorbid atopic dermatitis, vitiligo or anxiety/depression: TARGET-DERM AA
Read more →2023 · Poster Presentation · University of Chicago · Gastroenterology
Outcomes of early vs. delayed advanced therapy among patients with moderate ulcerative colitis in the United States: TARGET-IBD
Read more →2023 · Abstract/Manuscript · Northwestern University
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort
Read more →2023 · Abstract/Manuscript · UCSD
Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry
Read more →2022 · Poster Presentation · AbbVie Inc. · Dermatology
Epidemiology and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: a Cross Sectional Study from the TARGET-DERM AD Cohort (RAD 2021)
Read more →2022 · Poster Presentation · University of Chicago · Gastroenterology
The Impact of Early vs. Late Biologic Initiation Among Real World Patients with Crohn's Disease in TARGET IBD
Read more →2022 · Abstract/Manuscript · Northwestern University
Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort
Read more →2022 · Abstract/Manuscript · Atrium Health
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD
Read more →2021 · Abstract/Manuscript · Atrium Health
Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease
Read more →2021 · Abstract/Manuscript · University of Chicago
Methodology and initial results from a real-world observational cohort of patients with inflammatory bowel disease: TARGET-IBD
Read more →2020 · Poster Presentation · Atrium Health · Gastroenterology
Oral Mesalamine Use in Crohn's Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study (ECCO)
Read more →2020 · Poster Presentation · Atrium Health · Gastroenterology
Medication Use and Comorbidities Among Elderly as Compared to Younger Patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort (ACG)
Read more →2019 · Poster Presentation · Atrium Health · Gastroenterology
Oral Mesalamine Use in Crohn's Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study (ACG)
Read more →2018 · Poster Presentation · Atrium Health · Gastroenterology